Population
Human platelets
Design
Preclinical
Authors
Loading...
May inform novel antiplatelet strategies; leaves open clinical translation pending human studies.
Extracellular cGMP analogs inhibit human platelet activation via a cGK-independent mechanism, confirming the inhibitory rather than activating role of cGK pathways in platelets.
Gambaryan et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: